Skip to main content

CVS Health Corp

corporate_fare Company Profile

CVS Health Corp

CVS·NYSE·Trade & Services·CIK 0000064803

CVS Health Corporation is a leading health solutions company that connects care for consumers. As of December 31, 2025, the company operated approximately 9,000 retail locations and over 1,000 walk-in and primary care medical clinics. It also manages a pharmacy benefits manager serving approximately 87 million plan members, alongside expanding specialty pharmacy solutions. CVS Health provides traditional, voluntary, and consumer-directed health insurance products and related services to an estimated more than 37 million people. This includes growing Medicare Advantage offerings and a prominent standalone Medicare Part D prescription drug plan. The company aims to expand into personalized, technology-driven care delivery and health services. CVS Health operates through four reportable segments: Health Care Benefits, Health Services, Pharmacy & Consumer Wellness, and Corporate/Other. The Health Care Benefits segment, operating through its Aetna® operations, is one of the nation's leading diversified health care benefits providers, serving an estimated more than 37 million people as of December 31, 2025.

CVS Health Corp (NYSE:CVS) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 37 items for CVS at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • CVS Caremark to Drop J&J's Stelara, Prioritizing Biosimilars for Client Savings
  • CVS's Aetna Unit May Cut 2027 Medicare Advantage Benefits Amid Payment Concerns
  • CVS Health Achieves 88% Prior Authorization Standardization, Eliminating 1M+ Provider Calls
  • CVS Distribution Center Workers Authorize Strike in Virginia, Threatening Mid-Atlantic Supply
  • CVS, IRS Near Settlement in $402M Tax Lawsuit, Removing Financial Uncertainty

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$402.07B
Net Income
$1.77B
Diluted EPS
$1.39
Op. Cash Flow
$10.64B
Free Cash Flow
$7.81B
Gross Profit
$180.9B
Operating Income
$4.66B
Cash & Equivalents
$8.45B
Total Debt
$0
Debt / Equity
0.00×
Net Margin
0.4%
Shares Outstanding
1.27B sh
Source: 10-K · filed 2026-02-10 · accession 0000064803-26-000010
$89.05 +0.21% today
52-week range · as of 2026-08-05 $61.35 – $110.68
Market cap
$113.62B
Volume
21.9M (3.1× avg)
3-mo avg 7M
Live data · 2026-09-20 17:41 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CVS - Filings & News (Page 2)

CVS
May 05, 2026, 9:11 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $82.17
Real-time Price: $89.05 info
Change: +$6.89 (+8%) info
Market Cap: $113.624B info
CVS
May 01, 2026, 4:05 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $82.09
Real-time Price: $89.05 info
Change: +$6.96 (+8%) info
Market Cap: $113.624B info
CVS
Apr 24, 2026, 4:04 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $77.94
Real-time Price: $89.05 info
Change: +$11.11 (+14%) info
Market Cap: $113.624B info
CVS
Apr 16, 2026, 12:53 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $75.45
Real-time Price: $89.05 info
Change: +$13.60 (+18%) info
Market Cap: $113.624B info
CVS
Apr 09, 2026, 5:40 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $78.71
Real-time Price: $89.05 info
Change: +$10.34 (+13%) info
Market Cap: $113.624B info
CVS
Apr 03, 2026, 4:05 PM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $73.68
Real-time Price: $89.05 info
Change: +$15.37 (+21%) info
Market Cap: $113.624B info
CVS
Apr 03, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $73.68
Real-time Price: $89.05 info
Change: +$15.37 (+21%) info
Market Cap: $113.624B info
CVS
Apr 01, 2026, 3:07 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $72.48
Real-time Price: $89.05 info
Change: +$16.57 (+23%) info
Market Cap: $113.624B info
CVS
Mar 30, 2026, 1:12 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $70.03
Real-time Price: $89.05 info
Change: +$19.02 (+27%) info
Market Cap: $113.624B info
CVS
Mar 30, 2026, 2:47 AM EDT
Source: ShareCast
Importance Score:
8
Price at Filing: $70.07
Real-time Price: $89.05 info
Change: +$18.98 (+27%) info
Market Cap: $113.624B info
CVS
Mar 24, 2026, 12:34 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $71.58
Real-time Price: $89.05 info
Change: +$17.47 (+24%) info
Market Cap: $113.624B info
CVS
Mar 19, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $72.14
Real-time Price: $89.05 info
Change: +$16.91 (+23%) info
Market Cap: $113.624B info
CVS
Mar 11, 2026, 11:58 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $76.18
Real-time Price: $89.05 info
Change: +$12.87 (+17%) info
Market Cap: $113.624B info
CVS
Mar 06, 2026, 3:03 PM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $78.34
Real-time Price: $89.05 info
Change: +$10.71 (+14%) info
Market Cap: $113.624B info
CVS
Mar 05, 2026, 9:01 AM EST
Source: Reuters
Importance Score:
8
Price at Filing: $80.00
Real-time Price: $89.05 info
Change: +$9.05 (+11%) info
Market Cap: $113.624B info
CVS
Feb 10, 2026, 6:36 AM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $73.75
Real-time Price: $89.05 info
Change: +$15.30 (+21%) info
Market Cap: $113.624B info
CVS
Feb 10, 2026, 6:31 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $76.09
Real-time Price: $89.05 info
Change: +$12.96 (+17%) info
Market Cap: $113.624B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets